TFFP - TFF Pharmaceuticals Inc. (TFFP) CEO Glenn Mattes on Q2 2021 Results - Earnings Call Transcript
TFF Pharmaceuticals, Inc. (TFFP) Q2 2021 Earnings Conference Call August 12, 2021 04:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President & Chief Executive Officer Dale Christensen - Director of Clinical Development Kirk Coleman - Chief Financial Officer Bill Williams - University of Texas, Austin Chris Cano - Chief Operating Officer & Head of Business Development Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Michael Okunewitch - Maxim Group Sahil Kazmi - B. Riley Securities Daniel Carlson - TW Research Group Richard Deutsch - National Securities Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. As a reminder, this conference is being recorded. I will now turn the call over to our host Corey Davis of LifeSci Advisors. You may begin your conference. Corey Davis Thank you, operator. Hello, everyone and welcome to
For further details see:
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2021 Results - Earnings Call Transcript